References:
  1. Ferguson et al (2020), “Impact of non-pharmaceutical interventions (NPIs) to reduce COVID- 19 mortality and healthcare demand”, Imperial College COVID 19 Response team report, 16 March 2020.
  2. Dion Bongaerts, Francesco Mazzola and Wolf Wagner (2020), “Closed for Business”, CEPR Discussion Paper 14814, May 2020.
  3. José  Lourenço​​,  Robert  Paton​​,  Mahan  Ghafari​​,Moritz  Kraeme,  Craig  Thompson,  Peter  Simmonds​​, Paul Klenerman​​, Sunetra Gupta (2020), “Fundamental principles of epidemic spread highlight the immediate need for large-scale serological surveys to assess the stage of the SARS-CoV-2 epidemic “, medRxiv preprint doi: https://doi.org/10.1101/2020.03.24.20042291, March 2020.
  4. Mike Stedman, Mark Davies, Mark Lunt, Arpana Verma, Simon G. Anderson and Adrian H Heald (2020), “A phased approach to unlocking during the COVID-19 pandemic – Lessons from trend analysis”. Int J Clin Pract. 2020 May 7:e13528. doi: 10.1111/ijcp.13528.
  5. Oscar Dimdore-Miles and David Miles (2020), “Assessing the Spread of the Novel Coronavirus In The Absence of Mass Testing”, Covid Economics, issue 16, pages 161-176, May 2020.
  6. T. Wieland (2020) “Flatten the Curve! Modelling SARS-CoV-2/COVID-19 Growth in Germany on the County Level”, pre-print available at https://www.medrxiv.org/content/10.1101/2020.05.14.20101667v2.
  7. Karl J. Friston, Thomas Parr, Peter Zeidman, Adeel Razi, Guillaume Flandin, Jean Daunizeau, Oliver J. Hulme, Alexander J. Billig, Vladimir Litvak, Rosalyn J. Moran, Cathy J. Price and Christian Lambert (2020) “Dynamic Causal Modelling of COVID 19”, Technical Report available at https://arxiv.org/ftp/arxiv/papers/2004/2004.04463.pdf.
  8. Michael Levitt (2020) “The Corona Chronologies” available at: “https://www.dropbox.com/s/r4gxdvlcnrxet1i/1.The_Corona_Chronologies.%20Part%20I%20-%20China.%20Part%20II.%20Rest_of_World_Michael_Levitt%2CStanford_r.pdf?dl=0.
  9. Benjamin Born, Alexander M. Dietrich and Gernot J. Müller (2020), “Do lockdowns work? A counterfactual for Sweden”, Covid Economics, issue 16, May 2020.
  10. Dirk Krueger, Harald Uhlig and Taojun Xie (2020), “Macroeconomic dynamics and reallocation in an epidemic”, Covid Economics, vol 5, April 2020.
  11. https://www.ft.com/content/a26fbf7e-48f8-11ea-aeb3-955839e06441: accessed 12 June 2020
  12. Pragyan Deb, Davide Furceri, Jonathan D. Ostry and Nour Tawk (2020), “The economic effects of Covid-19 containment measures”. COVID Economics, CEPR, vol 24. May 2020.
  13. Barthélémy Bonadio, Zhen Huo, Andrei A. Levchenko, Nitya Pandalai-Nayar (2020), “Global Supply Chains in the Pandemic”, NBER Working Paper 27224, May 2020.
  14. Sangmin Aum, Sang Yoon (Tim) Lee, Yongseok Shin (2020), “Doesn’t Need Lockdowns to Destroy Jobs: The Effect of Local Outbreaks in Korea”, CEPR Discussion Paper 14822.
  15. Olivier Coibion, Yuriy Gorodnichenko and Michael Weber (a, 2020), “Labor markets during the Covid-19 crisis: A preliminary view”, COVID Economics, vol 21. May 2020, a.
  16. Olivier Coibion, Yuriy Gorodnichenko and Michael Weber (b, 2020), “The cost of the COVID-19 crisis: Lockdowns, macroeconomic expectations, and consumer spending”, Covid Economics, issue 20, May 2020.
  17. https://www.bankofengland.co.uk/-/media/boe/files/monetary-policy-report/2020/may/monetary-policy-report-may-2020#:accessed 11 June 2020.
  18. http://www.pulsetoday.co.uk/clinical/clinical-specialties/respiratory-/gp-urgent-cancer-referrals-decline-by-more-than-70-as-fewer-patients-come-forward/20040662.article: accessed 11 June 2020.
  19. https://www.england.nhs.uk/statistics/statistical-work-areas/hospital-activity/monthly-hospital-activity/mar-data/: accessed 11 June 2020.
  20. NICE (2013), “How NICE measures value for money in relation to public health interventions”, Published: 1 September 2013 at: nice.org.uk/guidance/lgb10.
  21. https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/lifeexpectancies/datasets/nationallifetablesunitedkingdomreferencetables: accessed 10 June 2020.
  22. Jonathan Valabhji, Naomi Holman, Peter Knighton, Partha Kar, Jackie O’Keefe, Matt Curley, Andy Weaver, Emma Barron, Chirag Bakhai, Kamlesh Khunti, Nick Wareham, Naveed Sattar, Bob Young (2020) “ Type 1 and Type 2 diabetes and COVID-19 related mortality in England: a cohort study in people with diabetes”, preprint available at https://www.england.nhs.uk/wp-content/uploads/2020/05/Valabhji-COVID-19-and-Diabetes-Paper-2-Full-Manuscript.pdf.
  23. https://digital.nhs.uk/data-and-information/publications/statistical/national-diabetes-audit/report-2--complications-and-mortality-2017-18: accessed 10 June 2020.
  24. Clarke P, Gray A, Holman R. (2002) “Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62)”. Med Decision Making. 22: pages 340-349
  25. A Beaudet, J Clegg, P Thuresson, A Lloyd, P McEwan (2014) “Review of Utility Values for Economic Modeling in Type 2 Diabetes”, Value in Health, Volume 17, Issue 4, June 2014, Pages 462-470
  26. Arulampalam, W, P Gregg and M Gregory (2001), “Unemployment Scarring”, The Economic Journal 111(475): F577-F584
  27. Tumino, A (2015), “The scarring effect of unemployment from the early ‘90s to the Great Recession”, Institute for Economic and Social Research Working Paper 2015
  28. Carol Propper, George Stoye and Ben Zaranko (2020), “The wider impacts of the coronavirus pandemic on the NHS”, IFS briefing (available at https://www.ifs.org.uk/publications/14798), April 2020.
  29. E P Gentry, W K Viscusi. The fatality and morbidity components of the value of a statistical life. Journal of Health Economics, volume 46, p. 90 – 99.
  30. Kevin M. Murphy and Robert H. Topel. The Value of Health and Longevity. Journal of Political Economy 2006 114:5, 871-904.
  31. Joshua R. Goldstein and Ronald D. Lee (2020), “ Demographic Perspectives on Mortality of COVID-19 and other Pandemics”, NBER Working Paper 27043.